Bruker (BRKR) Stock Forecast: StockMap's 2-Week Call
BRKR stock forecast: StockMap's model makes no two-week call on Bruker after the Nov 13 close: its evidence is split, 2 reasons for and 13 against. Right in 2 of 3 two-week windows on BRKR since Sep 24; by chance, a call on the same dates was right 51% of the time.
Bruker last closed at $61.59, +2.09% on the session.
Against the IVW growth benchmark the position is +3.00% over the forecast window.
Bruker's market cap is $9.41B as of November 13, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -13 (too close to call).
Where BRKR sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 2 bullish and 13 bearish.
Agreement across those insights is 87%.
17 daily calls for BRKR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Bruker in the 33rd percentile on return on equity, where 100 is best.
Bruker is classified under Health Care / Life Sciences Tools & Services.
StockMap tracks Bruker as the 18th largest of the 42 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 25 Neutral, 13 Moderate Outperform, 3 Moderate Underperform and 1 Strong Underperform.
On that composite Bruker ranks 37th of 42 in the group, against a group median of +0.13.